{"url":"https://lda.senate.gov/api/v1/filings/7d83ad7b-e298-4e91-967f-5496713d7b83/","filing_uuid":"7d83ad7b-e298-4e91-967f-5496713d7b83","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2022,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7d83ad7b-e298-4e91-967f-5496713d7b83/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark Lindsay","dt_posted":"2022-07-20T15:46:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"499 South Capitol St SW # 600","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":400395867,"url":"https://lda.senate.gov/api/v1/registrants/400395867/","house_registrant_id":null,"name":"BELL & LINDSAY, INC.","description":"Lobbying and Consulting","address_1":"425 3rd St SW # 1250","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK LINDSAY","contact_telephone":"+1 202-905-7345","dt_updated":"2026-07-29T13:54:27.680662-04:00"},"client":{"id":206156,"url":"https://lda.senate.gov/api/v1/clients/206156/","client_id":467,"name":"VIVOS THERAPEUTICS, INC.","general_description":"Medical technology company focused on sleeping and breathing disorders.","client_government_entity":false,"client_self_select":null,"state":"CO","state_display":"Colorado","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-07-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General consulting","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49748,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":"F","last_name":"LINDSAY","suffix":null,"suffix_display":null},"covered_position":"Assistant to the President The White House","new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}